
Philippe Bonnet
Harm Reduction Coordinator – Birmingham, The Hepatitis C Trust
Alternative NSP Delivery
17–18 September 2026 · Bristol
Voices from across research, services, policy and lived experience, speaking and chairing sessions across the two days.

Harm Reduction Coordinator – Birmingham, The Hepatitis C Trust
Alternative NSP Delivery

Peer Coordinator – North East & North Cumbria, The Hepatitis C Trust
To be confirmed

Managing Director, The Centre for Public Innovation
Understanding NSP provision in London – findings from a mapping exercise

Consultant in Public Health, Greater London Authority
Understanding NSP provision in London – findings from a mapping exercise

Consultant Epidemiologist and Head of the Hepatitis Section, UK Health Security Agency
The National Picture
Principal Scientist, Drugs & Infections team, UK Health Security Agency
The National Picture

Executive Director, Release
Uncracking the legality of paraphernalia laws: the case for reform

Councillor for St George Central ward, Bristol, Bristol City Council (Green Party) · Transform Drug Policy Foundation
To be confirmed

Executive Director, Harm Reduction International (HRI)
Protecting Progress: Harm Reduction, Hepatitis C Elimination and the UK’s Global Leadership

Senior Lecturer and Pharmacist Prescriber, Centre for Academic Primary Care, University of Bristol · Turning Point
Session chair
Chairing a session

Welfare & Trans Harm Reduction Specialist Worker, Safe Only CIC
What can we learn from Queer Community Harm Reduction Practices?
Doctoral Researcher in Public Health & Policy, Queen Mary University of London
Pleasure, Platforms and Public Health: Rethinking Harm Reduction in Chemsex

Head of Drugs Services, Release
Session chair
Chairing a session

Researcher & Partnerships Lead with Lived Experience, CRCHUM / CRISM – Quebec Node
Peer-Led Strategies for Equitable Engagement of People Who Use Drugs in Care and Research

National Harm Reduction Lead, Change Grow Live
Why we need separate, and separately funded, harm reduction and treatment services

Head of Harm Reduction, Cranstoun
Why we need separate, and separately funded, harm reduction and treatment services

Public Health Researcher / Public Health Consultant (FFPH), University of Bristol
‘Drugs: It’s Complicated’ – Co-developing and Evaluating Films Intended to Reduce Stigma Towards People Who Use Criminalised Drugs

PhD Candidate, University of Manchester
We are Fearless Women: Examining the Impact of New Public Management on Women’s Access to Harm Reduction Services in England

National Diverse Communities Lead, Turning Point
Breaking Barriers, Not Building Services Around Them — A Community Approach to Harm Reduction

Executive Medical Director, Change Grow Live
Optimising Opioid Medication-Assisted Treatment: Reducing Drug-Related Harm through the AAAQ Framework

Senior Peer Educator / Peer Researcher, The Hepatitis C Trust
The Power of Peer Research